The Medicare Advantage Medical Policies are designed to provide guidance regarding the decision-making process for the coverage or non-coverage of services or procedures in accordance with the member EOC and the Centers of Medicare and Medicaid Services (CMS) policies, when available. In the event of a conflict, applicable CMS policy or EOC language will

DESCRIPTION
"Deep brain stimulation (DBS) refers to high-frequency electrical stimulation of anatomic regions deep within the brain utilizing neurosurgically implanted electrodes. These DBS electrodes are stereotactically placed within targeted nuclei on one (unilateral) or both (bilateral) sides of the brain. There are currently three targets for DBS --the thalamic ventralis intermedius nucleus (VIM), subthalamic nucleus (STN) and globus pallidus interna (GPi)." [1] MEDICARE ADVANTAGE POLICY CRITERIA CMS Coverage Manuals* See References [1] National Coverage Determinations (NCDs)* 
POLICY GUIDELINES REQUIRED DOCUMENTATION
The information below must be submitted for review to determine whether policy criteria are met. If any of these items are not submitted, it could impact our review and decision outcome:
• Condition intended to be treated (Parkinson's disease, essential tremor, a motor function disorder such as multiple sclerosis, intractable pain, etc.); • Bilateral or unilateral stimulation;
• targeted nuclei o thalamic ventralis intermedius nucleus (VIM) o subthalamic nucleus (STN) or o globus pallidus interna (GPi);
• Name of device (only FDA-approved devices or devices used within the context of a Category B IDE clinical trial will be considered for coverage); • If chronic intractable pain is the condition being treated, include the following:
o Documentation of other treatments that have attempted and failed or determined to be unsuitable or contraindicated for the individual patient (implantation of the stimulator should be used only as a last resort); o Medical records with history, physical, evaluation and screening (physical and psychological) prior to implantation; and, o Demonstrated pain relief with temporarily implanted electrode should proceed permanent implantation.
REGULATORY STATUS
The U.S. Food and Drug Administration (FDA) has approved the following devices:
• Activa ® Tremor Control System (Medtronic Corp.) is approved for deep brain stimulation.
• 
